Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 1994-02-01 (32 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE THOR (84250), Vaucluse
PHARMACIE DU MARCHE : revenue, balance sheet and financial ratios
PHARMACIE DU MARCHE is a French company
founded 32 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE THOR (84250),
this company of category PME
shows in 2022 a revenue of 3.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU MARCHE (SIREN 394063259)
Indicator
2024
2023
2022
2021
2020
2019
2018
2018
2017
2016
Revenue
N/C
N/C
3 476 706 €
N/C
N/C
N/C
N/C
N/C
3 007 235 €
3 032 581 €
Net income
201 708 €
179 881 €
372 974 €
407 573 €
271 112 €
161 040 €
43 371 €
74 762 €
82 747 €
276 270 €
EBITDA
N/C
N/C
493 612 €
N/C
N/C
N/C
N/C
N/C
140 794 €
324 012 €
Net margin
N/C
N/C
10.7%
N/C
N/C
N/C
N/C
N/C
2.8%
9.1%
Revenue and income statement
In 2024, PHARMACIE DU MARCHE generates positive net income of 202 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 276 k€ -> 202 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
201 708 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 78%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
78.205%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
45.293%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2018
2019
2020
2021
2022
2023
2024
Debt ratio
477.893
1446.898
708.953
522.085
349.725
294.896
205.803
172.341
105.036
78.205
Financial autonomy
14.73
5.222
9.529
13.208
18.536
19.84
26.876
31.302
40.147
45.293
Repayment capacity
4.595
13.269
None
None
None
None
None
3.789
None
None
Cash flow / Revenue
9.99%
3.545%
None%
None%
None%
None%
None%
10.377%
None%
None%
Sector positioning
Debt ratio
78.22024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average-17 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU MARCHE (78.20) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
45.29%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+16 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU MARCHE (45.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
3.79 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DU MARCHE (3.79) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 206.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
206.811
Liquidity indicators evolution PHARMACIE DU MARCHE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
217.562
153.028
116.852
102.823
224.2
200.025
262.732
324.74
225.112
206.811
Interest coverage
9.699
20.158
None
None
None
None
None
1.718
None
None
Sector positioning
Liquidity ratio
206.812024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good-17 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DU MARCHE (206.81) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
1.72x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMACIE DU MARCHE (1.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 173 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 675 days. Excellent situation: suppliers finance 502 days of the operating cycle (retail model).
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
173 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
675 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU MARCHE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2018
2019
2020
2021
2022
2023
2024
Operating WCR
478 541 €
374 010 €
0 €
0 €
0 €
0 €
0 €
785 944 €
0 €
0 €
Inventory turnover (days)
38
44
0
0
0
0
0
42
0
0
Customer payment term (days)
7
8
0
0
0
0
11
8
182
173
Supplier payment term (days)
30
35
0
0
0
0
768
40
703
675
Positioning of PHARMACIE DU MARCHE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU MARCHE is estimated at
2 815 992 €
(range 1 961 012€ - 4 212 886€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1961k€2815k€4212k€
2 815 992 €Range: 1 961 012€ - 4 212 886€
NAF 5 année 2024
Valuation method used
Net Income Multiple
201 708 €
×
14.0x
=2 815 993 €
Range: 1 961 013€ - 4 212 886€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU MARCHE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU MARCHE
What is the revenue of PHARMACIE DU MARCHE ?
The revenue of PHARMACIE DU MARCHE in 2022 is 3.5 M€.
Is PHARMACIE DU MARCHE profitable?
Yes, PHARMACIE DU MARCHE generated a net profit of 202 k€ in 2024.
Where is the headquarters of PHARMACIE DU MARCHE ?
The headquarters of PHARMACIE DU MARCHE is located in LE THOR (84250), in the department Vaucluse.
Where to find the tax return of PHARMACIE DU MARCHE ?
The tax return of PHARMACIE DU MARCHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU MARCHE operate?
PHARMACIE DU MARCHE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart